ARCHIVES

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

This article is from The Cancer Letter archive.

Vol. 24 No. 33 | September 4, 1998

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

RFA On etiology Of AIDS, Kaposi’s

June 3, 1983